Qualitative investigation into a wearable system for chronic obstructive pulmonary disease: the stakeholders' perspective.

Reem Kayyali, Vilius Savickas, Martijn A Spruit, Evangelos Kaimakamis, Roshan Siva, Richard W Costello, John Chang, Barbara Pierscionek, Nikki Davies, Anouk W Vaes, Rita Paradiso, Nada Philip, Eleni Perantoni, Shona D'Arcy, Andreas Raptopoulos, Shereen Nabhani-Gebara
Author Information
  1. Reem Kayyali: Faculty of Science, Engineering and Computing, Kingston University, Kingston-Upon-Thames, UK.
  2. Vilius Savickas: Faculty of Science, Engineering and Computing, Kingston University, Kingston-Upon-Thames, UK.
  3. Martijn A Spruit: Department of Research and Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands.
  4. Evangelos Kaimakamis: Pulmonary Clinic, General Hospital G.P. Papanikolaou, Thessaloniki, Greece.
  5. Roshan Siva: Chest Clinic and Research and Development, Croydon University Hospital, Croydon, UK.
  6. Richard W Costello: RCSI Education & Research Centre, RCSI, Dublin, Ireland.
  7. John Chang: Chest Clinic and Research and Development, Croydon University Hospital, Croydon, UK.
  8. Barbara Pierscionek: Faculty of Science, Engineering and Computing, Kingston University, Kingston-Upon-Thames, UK.
  9. Nikki Davies: Chest Clinic and Research and Development, Croydon University Hospital, Croydon, UK.
  10. Anouk W Vaes: Department of Research and Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands.
  11. Rita Paradiso: Research and Development, Smartex s.r.l, Pisa, Italy.
  12. Nada Philip: Faculty of Science, Engineering and Computing, Kingston University, Kingston-Upon-Thames, UK.
  13. Eleni Perantoni: Chest Clinic and Research and Development, Croydon University Hospital, Croydon, UK.
  14. Shona D'Arcy: RCSI Education & Research Centre, RCSI, Dublin, Ireland.
  15. Andreas Raptopoulos: Research and Development, Exodus Information Technology S.A, Athens, Greece.
  16. Shereen Nabhani-Gebara: Faculty of Science, Engineering and Computing, Kingston University, Kingston-Upon-Thames, UK.

Abstract

OBJECTIVES: To ascertain the stakeholders' views and devise recommendations for further stages of the Wearable Sensing and Smart Cloud Computing for Integrated Care to Chronic Obstructive Pulmonary Disease (COPD) Patients with Co-morbidities (WELCOME) system development. This system aims to create a wearable vest to monitor physiological signals for patients concerned incorporating an inhaler adherence monitoring, weight, temperature, blood pressure and glucose metres, and a mobile health application for communication with healthcare professionals (HCPs).
DESIGN: A study of qualitative data derived from focus groups and semistructured interviews.
SETTING: 4 participating clinical sites in Greece, the UK, Ireland and the Netherlands.
PARTICIPANTS: Purposive sampling was used to recruit 32 patients with COPD with heart failure, diabetes, anxiety or depression, 27 informal carers and 23 HCPs from 4 European Union (EU) countries for focus groups and interviews.
RESULTS: Most patients and HCPs described the WELCOME system as 'brilliant and creative' and felt it gave a sense of safety. Both users and HCPs agreed that the duration and frequency of vest wear should be individualised as should the mobile application functions. The parameters and frequency of monitoring should be personalised using a multidisciplinary approach. A 'traffic light' alert system was proposed by HCPs for abnormal results. Patients were happy to take actions in response.
CONCLUSIONS: WELCOME stakeholders provided valuable views on the development of the system, which should take into account patient's individual comorbidities, circumstances and concerns. This will enable the development of the individualised system in each member state concerned.

Keywords

References

  1. Eur Heart J. 2005 Sep;26(18):1887-94 [PMID: 15860516]
  2. Respir Care. 2012 Feb;57(2):263-72 [PMID: 21762551]
  3. J Telemed Telecare. 2015 Mar;21(2):108-18 [PMID: 25586810]
  4. Br J Gen Pract. 2014 Jul;64(624):e392-400 [PMID: 24982491]
  5. JMIR Mhealth Uhealth. 2014 Oct 21;2(4):e42 [PMID: 25338094]
  6. Chest. 2015 Mar;147(3):662-72 [PMID: 25340477]
  7. Chest. 2010 Feb;137(2):341-7 [PMID: 19801582]
  8. Int J Clin Pract. 2009 May;63(5):742-50 [PMID: 19392924]
  9. Am J Manag Care. 2015 May;21(5):355-62 [PMID: 26167702]
  10. Int J Chron Obstruct Pulmon Dis. 2014 Mar 29;9:315-30 [PMID: 24729698]
  11. Conf Proc IEEE Eng Med Biol Soc. 2014;2014:3180-3 [PMID: 25570666]
  12. Eur Respir J. 1998 May;11(5):1178-81 [PMID: 9648974]
  13. Chest. 2008 Oct;134(4 Suppl):43S-56S [PMID: 18842932]
  14. Prim Care Respir J. 2013 Mar;22(1):64-71 [PMID: 23299455]
  15. Psychiatry Res. 2005 Feb 28;133(2-3):129-33 [PMID: 15740989]
  16. Int J Med Inform. 2015 Oct;84(10):835-46 [PMID: 26190049]
  17. BMJ. 2012 Jun 21;344:e3874 [PMID: 22723612]
  18. Ann Thorac Med. 2011 Oct;6(4):242-3 [PMID: 21977074]
  19. Clin Respir J. 2014 Oct;8(4):397-403 [PMID: 24308876]
  20. J Am Med Inform Assoc. 2009 Jul-Aug;16(4):550-60 [PMID: 19390112]
  21. Cochrane Database Syst Rev. 2014 Mar 19;(3):CD002990 [PMID: 24665053]
  22. Stud Health Technol Inform. 2014;205:353-7 [PMID: 25160205]
  23. Heart Lung. 2006 Jan-Feb;35(1):46-57 [PMID: 16426935]
  24. Respir Med. 2012 Sep;106(9):1342-50 [PMID: 22795984]
  25. Arch Intern Med. 2007 Jan 8;167(1):60-7 [PMID: 17210879]
  26. BMJ Open. 2013 Sep 18;3(9):e003250 [PMID: 24048626]
  27. Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65 [PMID: 22878278]
  28. Prim Care Respir J. 2012 Sep;21(3):322-8 [PMID: 22875143]
  29. Health Econ Policy Law. 2012 Jan;7(1):125-46 [PMID: 22221931]
  30. J Telemed Telecare. 2015 Jan;21(1):29-36 [PMID: 25475218]
  31. Respir Med. 2014 Mar;108(3):453-62 [PMID: 24433744]
  32. COPD. 2012 Dec;9(6):611-9 [PMID: 22946768]
  33. Diabetes Technol Ther. 2015 Aug;17(8):563-70 [PMID: 26154338]
  34. Eur Respir J. 2008 Oct;32(4):962-9 [PMID: 18579551]
  35. Chest. 2005 Apr;127(4):1205-11 [PMID: 15821196]
  36. Lancet Respir Med. 2015 Mar;3(3):210-9 [PMID: 25617215]
  37. Int J Chron Obstruct Pulmon Dis. 2015 Jun 08;10:1061-73 [PMID: 26089656]
  38. BMJ. 2013 Oct 17;347:f6070 [PMID: 24136634]
  39. Public Health Nurs. 1993 Dec;10(4):245-51 [PMID: 8309892]
  40. Am J Respir Crit Care Med. 2010 Oct 1;182(7):890-6 [PMID: 20075385]
  41. J Telemed Telecare. 2004;10 (4):226-30 [PMID: 15273033]

MeSH Term

Aged
Aged, 80 and over
Comorbidity
Female
Focus Groups
Greece
Humans
Interviews as Topic
Ireland
Male
Middle Aged
Mobile Applications
Monitoring, Physiologic
Netherlands
Pulmonary Disease, Chronic Obstructive
Qualitative Research
Stakeholder Participation
Telemedicine
United Kingdom
Wearable Electronic Devices

Word Cloud

Created with Highcharts 10.0.0systemHCPsWELCOMEdevelopmentpatientsstakeholders'viewsCOPDPatientswearablevestconcernedmonitoringmobileapplicationfocusgroupsinterviews4frequencyindividualisedtakeOBJECTIVES:ascertaindeviserecommendationsstagesWearableSensingSmartCloudComputingIntegratedCareChronicObstructivePulmonaryDiseaseCo-morbiditiesaimscreatemonitorphysiologicalsignalsincorporatinginhaleradherenceweighttemperaturebloodpressureglucosemetreshealthcommunicationhealthcareprofessionalsDESIGN:studyqualitativedataderivedsemistructuredSETTING:participatingclinicalsitesGreeceUKIrelandNetherlandsPARTICIPANTS:Purposivesamplingusedrecruit32heartfailurediabetesanxietydepression27informalcarers23EuropeanUnionEUcountriesRESULTS:described'brilliantcreative'feltgavesensesafetyusersagreeddurationwearfunctionsparameterspersonalisedusingmultidisciplinaryapproach'trafficlight'alertproposedabnormalresultshappyactionsresponseCONCLUSIONS:stakeholdersprovidedvaluableaccountpatient'sindividualcomorbiditiescircumstancesconcernswillenablememberstateQualitativeinvestigationchronicobstructivepulmonarydisease:perspectiveRESPIRATORYMEDICINEseeThoracicMedicine

Similar Articles

Cited By